Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rituximab in Progressive IgA Nephropathy

This study has been completed.
Ohio State University
Stanford University
University of North Carolina, Chapel Hill
Columbia University
Information provided by (Responsible Party):
Fernando Fervenza, Mayo Clinic Identifier:
First received: July 9, 2007
Last updated: October 23, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):